Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIO-TECHNE Corp | Director | Common Stock | 13.8K | $1.01M | $73.20 | Oct 24, 2024 | Direct |
Keros Therapeutics, Inc. | Director | Stock Option (right to buy) | 10K | May 30, 2024 | Direct | ||
BIO-TECHNE Corp | Director | Stock Options (Right to Buy) | 3.94K | Oct 26, 2023 | Direct | ||
BIO-TECHNE Corp | Director | Stock Options (Right to Buy) | 3.51K | Oct 24, 2024 | Direct | ||
Seagen Inc. | Director | Common Stock | 0 | $229.00 | Dec 14, 2023 | Direct | |
Seagen Inc. | Director | Restricted Stock Units | 0 | $229.00 | Dec 14, 2023 | Direct | |
Seagen Inc. | Director | Stock Options (Right to Buy) | 0 | Dec 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TECH | BIO-TECHNE Corp | Oct 24, 2024 | 2 | $0 | 4 | Oct 28, 2024 | Director |
KROS | Keros Therapeutics, Inc. | May 30, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Director |
SGEN | Seagen Inc. | Dec 14, 2023 | 7 | -$2.97M | 4 | Dec 15, 2023 | Director |
TECH | BIO-TECHNE Corp | Oct 26, 2023 | 2 | $0 | 4 | Oct 30, 2023 | Director |
KROS | Keros Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
SGEN | Seagen Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
KROS | Keros Therapeutics, Inc. | May 1, 2023 | 1 | $0 | 4 | May 3, 2023 | Director |
KROS | Keros Therapeutics, Inc. | May 1, 2023 | 0 | $0 | 3 | May 3, 2023 | Director |
TECH | BIO-TECHNE Corp | Oct 27, 2022 | 2 | $0 | 4 | Oct 31, 2022 | Director |
SGEN | Seagen Inc. | May 13, 2022 | 2 | $0 | 4 | May 17, 2022 | Director |
TECH | BIO-TECHNE Corp | Oct 28, 2021 | 2 | $0 | 4 | Nov 1, 2021 | Director |
SGEN | Seagen Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |